Welcome To ChemAnalyst
As of mid-November 2025, the Methylamine market in India exhibited stable pricing, as a result of good production coordination, sound inventory management, and steady demand from primary end-user markets. Suppliers have effectively navigated production schedules, allocation method, and stock levels well enough to meet domestic demand, as well for selective export. This organized coordination of production also helped the Methylamine market avoid sharp pricing changes throughout the reporting process, even considering some minor end-use demand changes and regional supply situations.
Indiax;s leading producers, such as AACL, Balaji Amines, RCF, and Aarti Drugs, have a combined Methylamine production capacity of over xxx,xxx metric tonnes. AACL continues to run at strong run-rates, ensuring that there is sufficient volume availability into the market after its internal utilization. Aarti Drugs has recently started a new Methylamine capacity of xx–xx ktpa which is slowly being ramped up adding redundancy to overall supply. Balaji Amines recorded quarterly sales of xx,xxx metric tonnes in total; reiterated the renew of each category was amines - x,xxx MT; amine derivatives - x,xxx MT; and specialty chemicals - xx,xxx MT. The company said that margins were aided by better product mix and cost savings, allowing the market to operate in equilibrium and stabilize pricing.
The demand for methylamine remains solid, reflecting its use in pharmaceutical, agrochemical, and specialty chemical applications. The pharmaceutical application varies...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
